Skip to content

Home
Our research
Market
Plans
Partnering
About us

Menu

Home
Our research
Market
Plans
Partnering
About us

Information inför årsstämman

Under Investerare/Bolagsstyrning finns information och dokument tillgängliga inför årsstämman den 29 april 2015.

Contact us

Jens Eriksson

Twitter Linkedin Facebook Youtube

As part of Coegin Pharma AB’s hub & spoke “portfolio” business model, with clear benefits to investors, Coegin Pharma AB has established the Swedish portfolio company Follicum AB to further develop a highly promising derma cosmetic product line based on FOL005 to boost hair and support healthy hair growth. Follicum AB will primarily be managed and financed separately from Coegin Pharma AB.

© All Rights Reserved